Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

Discure Technologies Ltd: Valuation, Funding & Investors

Medinat hayehudim 85 Herzlyia, Israel 46140, ILhttps://www.discuremd.com/Medical Devices

Discure Technologies Ltd. specializes in the development of the Discure System, a bioelectronic implantable device designed to treat degenerative disc disease (DDD). The company's innovative solution aims to address the significant market need for effective treatments in the field of spinal health, leveraging advanced bioelectronic technology to improve patient outcomes.

Leadership & Board

Current Number of Employees: 13
Current LinkedIn Followers: 2,240

Latest Estimated Valuation

Total Amount Raised: $16M
Total Funding Rounds: 1
Latest Funding Amount: $16M
Latest Funding Round: Series A

Employee Trend

Discure Technologies Ltd had 13 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

13Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

Discure Technologies Ltd had 2,240 followers as of October 26, 2026. The number of followers increased by 0 (0.00%) week-over-week.

2,240Latest Followers Count

0(0.00%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
Aug 14, 2025	Series A	$16.00M	―

Investors

Investor Name	Funding Round
BOLD Capital Partners	Series A
Supernova Invest	Series A
Sanara Capital	Series A
multiple US hospital networks	Series A
leading orthopedic surgeons	Series A

Similar Companies

A snapshot of private companies similar to Discure Technologies Ltd, helping you discover and navigate related company profiles.

OneCell Diagnostics

HC Bioscience Inc

Related News and Analysis

Discure Technologies Ltd – Weekly Recap

Discure Technologies Ltd – Weekly Recap

Discure Technologies Ltd is the focus of this weekly recap, which highlights notable developments at the medtech company working on a new approach to treating degenerative disc disease. Over the

5M ago

Discure Technologies Adds Veteran Medtech Leader to Board and Clinical Leadership

Discure Technologies Adds Veteran Medtech Leader to Board and Clinical Leadership

According to a recent LinkedIn post from Discure Technologies Ltd, the company is adding Dr. Ray Baker to its Board of Directors and engaging him in a Chief Medical Officer

5M ago

Discure Technologies Adds Experienced Medtech Leader to Board and Clinical Strategy

Discure Technologies Adds Experienced Medtech Leader to Board and Clinical Strategy

According to a recent LinkedIn post from Discure Technologies Ltd, the company is adding Dr. Ray Baker to its Board of Directors while also engaging him in a Chief Medical

5M ago

Discure Technologies Ltd – Weekly Recap

Discure Technologies Ltd – Weekly Recap

Discure Technologies Ltd is a medtech company developing disease-modifying therapies for chronic back pain and degenerative disc disease, and this week’s updates highlight meaningful clinical and regulatory progress. The company

10M ago

Discure Technologies Gains FDA TAP Program Acceptance for Degenerative Disc Disease Therapy

Discure Technologies Gains FDA TAP Program Acceptance for Degenerative Disc Disease Therapy

Discure Technologies Ltd has shared an update. The company has been accepted into the U.S. Food and Drug Administration’s (FDA) Total Product Life Cycle Advisory Program (TAP Program), an initiative

10M ago

Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Signals Encouraging Early Results

Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Signals Encouraging Early Results

Discure Technologies Ltd has shared an update. The company announced completion of patient enrollment in its first-in-human clinical study, conducted in collaboration with Beam Radiology. Management reports that early results

10M ago

Discure Technologies Advances Toward Pivotal U.S. Trial for Chronic Back Pain Therapy

Discure Technologies Advances Toward Pivotal U.S. Trial for Chronic Back Pain Therapy

Discure Technologies Ltd has shared an update. The company reports that it has completed first-in-human enrollment for its chronic back pain therapy and is preparing for a pivotal clinical trial

10M ago

Discure Technologies Enters FDA TAP Program, Advancing Degenerative Disc Disease Therapy

Discure Technologies Enters FDA TAP Program, Advancing Degenerative Disc Disease Therapy

Discure Technologies Ltd has shared an update. The company announced its acceptance into the U.S. Food and Drug Administration’s (FDA) Total Product Life Cycle Advisory Program (TAP), an initiative aimed

10M ago

Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Plans to Reveal Early Data at Major Spine Conferences

Discure Technologies Completes Enrollment in First-in-Human Clinical Study, Plans to Reveal Early Data at Major Spine Conferences

Discure Technologies Ltd has shared an update. The company announced that patient enrollment has been completed in its first-in-human clinical study, conducted in partnership with Beam Radiology. Management indicated that

10M ago

Discure Technologies Advances Toward Pivotal U.S. Trial in Chronic Back Pain

Discure Technologies Advances Toward Pivotal U.S. Trial in Chronic Back Pain

Discure Technologies Ltd has shared an update. The company reports that it has completed first-in-human enrollment for its chronic back pain therapy and is preparing to initiate a pivotal clinical

10M ago